featured
Relugolix vs Placebo for Endometriosis-Associated Pain
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)
Lancet 2022 Jun 18;399(10343)2267-2279, LC Giudice, S As-Sanie, JC Arjona Ferreira, CM Becker, MS Abrao, BA Lessey, E Brown, K Dynowski, K Wilk, Y Li, V Mathur, QA Warsi, RB Wagman, NP JohnsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.